210 related articles for article (PubMed ID: 33070094)
21. Association of Plasma Neurofilament Light With Small Vessel Disease Burden in Nondemented Elderly: A Longitudinal Study.
Qu Y; Tan CC; Shen XN; Li HQ; Cui M; Tan L; Dong Q; Yu JT;
Stroke; 2021 Mar; 52(3):896-904. PubMed ID: 33517704
[TBL] [Abstract][Full Text] [Related]
22. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
Quiroz YT; Zetterberg H; Reiman EM; Chen Y; Su Y; Fox-Fuller JT; Garcia G; Villegas A; Sepulveda-Falla D; Villada M; Arboleda-Velasquez JF; Guzmán-Vélez E; Vila-Castelar C; Gordon BA; Schultz SA; Protas HD; Ghisays V; Giraldo M; Tirado V; Baena A; Munoz C; Rios-Romenets S; Tariot PN; Blennow K; Lopera F
Lancet Neurol; 2020 Jun; 19(6):513-521. PubMed ID: 32470423
[TBL] [Abstract][Full Text] [Related]
23. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
[TBL] [Abstract][Full Text] [Related]
24. Plasma neurofilament light chain levels in Alzheimer's disease.
Zhou W; Zhang J; Ye F; Xu G; Su H; Su Y; Zhang X;
Neurosci Lett; 2017 May; 650():60-64. PubMed ID: 28428015
[TBL] [Abstract][Full Text] [Related]
25. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
[TBL] [Abstract][Full Text] [Related]
26. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
27. Potential Value of Plasma Amyloid-β, Total Tau, and Neurofilament Light for Identification of Early Alzheimer's Disease.
Shi Y; Lu X; Zhang L; Shu H; Gu L; Wang Z; Gao L; Zhu J; Zhang H; Zhou D; Zhang Z
ACS Chem Neurosci; 2019 Aug; 10(8):3479-3485. PubMed ID: 31145586
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide association study identifies two loci influencing plasma neurofilament light levels.
Li JQ; Yuan XZ; Li HY; Cao XP; Yu JT; Tan L; Chen WA;
BMC Med Genomics; 2018 May; 11(1):47. PubMed ID: 29747637
[TBL] [Abstract][Full Text] [Related]
29. Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease.
Pereira JB; Westman E; Hansson O;
Neurobiol Aging; 2017 Oct; 58():14-29. PubMed ID: 28692877
[TBL] [Abstract][Full Text] [Related]
30. Racial differences in white matter hyperintensity burden in older adults.
Morrison C; Dadar M; Manera AL; Collins DL
Neurobiol Aging; 2023 Feb; 122():112-119. PubMed ID: 36543016
[TBL] [Abstract][Full Text] [Related]
31. Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer's disease.
Andersson E; Janelidze S; Lampinen B; Nilsson M; Leuzy A; Stomrud E; Blennow K; Zetterberg H; Hansson O
Neurobiol Aging; 2020 Nov; 95():143-153. PubMed ID: 32810755
[TBL] [Abstract][Full Text] [Related]
32. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
[TBL] [Abstract][Full Text] [Related]
33. APOE ε4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis.
Sudre CH; Cardoso MJ; Frost C; Barnes J; Barkhof F; Fox N; Ourselin S;
Neurobiol Aging; 2017 May; 53():67-75. PubMed ID: 28235680
[TBL] [Abstract][Full Text] [Related]
34. Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease.
Lewczuk P; Ermann N; Andreasson U; Schultheis C; Podhorna J; Spitzer P; Maler JM; Kornhuber J; Blennow K; Zetterberg H
Alzheimers Res Ther; 2018 Jul; 10(1):71. PubMed ID: 30055655
[TBL] [Abstract][Full Text] [Related]
35. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.
Pålhaugen L; Sudre CH; Tecelao S; Nakling A; Almdahl IS; Kalheim LF; Cardoso MJ; Johnsen SH; Rongve A; Aarsland D; Bjørnerud A; Selnes P; Fladby T
J Cereb Blood Flow Metab; 2021 May; 41(5):1162-1174. PubMed ID: 32955960
[TBL] [Abstract][Full Text] [Related]
36. Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease.
Parbo P; Madsen LS; Ismail R; Zetterberg H; Blennow K; Eskildsen SF; Vorup-Jensen T; Brooks DJ
Alzheimers Res Ther; 2020 Jan; 12(1):3. PubMed ID: 31898549
[TBL] [Abstract][Full Text] [Related]
37. White Matter Hyperintensities and Cognitive Impairment in Healthy and Pathological Aging: A Quantified Brain MRI Study.
Kaskikallio A; Karrasch M; Koikkalainen J; Lötjönen J; Rinne JO; Tuokkola T; Parkkola R; Grönholm-Nyman P
Dement Geriatr Cogn Disord; 2019; 48(5-6):297-307. PubMed ID: 32209796
[TBL] [Abstract][Full Text] [Related]
38. The Potential of Neurofilament Light as a Biomarker in Alzheimer's Disease.
Xiong YL; Meng T; Luo J; Zhang H
Eur Neurol; 2021; 84(1):6-15. PubMed ID: 33477142
[TBL] [Abstract][Full Text] [Related]
39. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.
Sjögren M; Blomberg M; Jonsson M; Wahlund LO; Edman A; Lind K; Rosengren L; Blennow K; Wallin A
J Neurosci Res; 2001 Nov; 66(3):510-6. PubMed ID: 11746370
[TBL] [Abstract][Full Text] [Related]
40. White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.
van den Berg E; Geerlings MI; Biessels GJ; Nederkoorn PJ; Kloppenborg RP
J Alzheimers Dis; 2018; 63(2):515-527. PubMed ID: 29630548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
